fda warns against compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA warns about safety of

Slowing down the emptying of the stomach can lead to problems like abdominal pain, nausea/vomiting and constipation

GLP-1 receptor agonist medications became some of the most widely prescribed drugs in the United States after demonstrating substantial effectiveness in diabetes treatment and weight management

While the two terms seem similar, the BUD is specifically assigned based on the day the medication was compounded or mixed

The PNS is comprised of the autonomic nervous system (ANS) and the somatic nervous system (SNS)

When the plasma glucose is less than 55 mg/dL, insulin production should cease

Mathieu C, Dandona P, Gillard P et al (2018) Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 Study): 24-week results from a randomized controlled trial